(Q38391223)

English

Chemoembolization combined with radiofrequency ablation for patients with hepatocellular carcinoma larger than 3 cm: a randomized controlled trial

scientific article published on April 2008

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

retracted paper

2 references

Dataset for "Continued use of retracted papers: Temporal trends in citations and (lack of) awareness of retractions shown in citation contexts in biomedicine"

Continued use of retracted papers: Temporal trends in citations and (lack of) awareness of retractions shown in citation contexts in biomedicine

Chemoembolization combined with radiofrequency ablation for patients with hepatocellular carcinoma larger than 3 cm: a randomized controlled trial (English)

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

hepatocellular carcinoma

1 reference

based on heuristic

inferred from title

author name string

Bao-Quan Cheng

1

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

Chong-Qi Jia

2

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

Chun-Tao Liu

3

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

Wei Fan

4

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

Qing-Liang Wang

5

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

Zong-Li Zhang

6

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

Cui-Hua Yi

7

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

language of work or name

0 references

publication date

1 April 2008

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

The Journal of the American Medical Association

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

299

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

14

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

1669-1677

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

Percutaneous radiofrequency ablation of hepatocellular carcinoma as a bridge to liver transplantation

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1001/JAMA.299.14.1669

Reporting results of cancer treatment

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1001/JAMA.299.14.1669

HCC surveillance: Who is the target population?

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1001/JAMA.299.14.1669

Validation of a new prognostic staging system for hepatocellular carcinoma: The JIS score compared with the CLIP score

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1001/JAMA.299.14.1669

Systematic review of randomized trials for unresectable hepatocellular carcinoma: Chemoembolization improves survival

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1001/JAMA.299.14.1669

Performance status assessment in cancer patients. An inter-observer variability study

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1001/JAMA.299.14.1669

Transection of the oesophagus for bleeding oesophageal varices

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1001/JAMA.299.14.1669

Natural history of hepatocellular carcinoma and prognosis in relation to treatment. Study of 850 patients

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1001/JAMA.299.14.1669

Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1001/JAMA.299.14.1669

Prognostic prediction and treatment strategy in hepatocellular carcinoma.

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1001/JAMA.299.14.1669

Hepatocellular carcinoma

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1001/JAMA.299.14.1669

A randomized controlled trial of radiofrequency ablation with ethanol injection for small hepatocellular carcinoma.

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1001/JAMA.299.14.1669

Radiofrequency ablation improves prognosis compared with ethanol injection for hepatocellular carcinoma < or =4 cm.

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1001/JAMA.299.14.1669

A comparison of lipiodol chemoembolization and conservative treatment for unresectable hepatocellular carcinoma

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1001/JAMA.299.14.1669

Prospective cohort study of transarterial chemoembolization for unresectable hepatocellular carcinoma in 8510 patients

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1001/JAMA.299.14.1669

Radiofrequency thermal ablation (RFA) after transarterial chemoembolization (TACE) as a combined therapy for unresectable non-early hepatocellular carcinoma (HCC).

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1001/JAMA.299.14.1669

Percutaneous radio-frequency thermal ablation of nonresectable hepatocellular carcinoma after occlusion of tumor blood supply

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1001/JAMA.299.14.1669

Prospective validation of the CLIP score: a new prognostic system for patients with cirrhosis and hepatocellular carcinoma. The Cancer of the Liver Italian Program (CLIP) Investigators

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1001/JAMA.299.14.1669

Transcatheter chemo-embolization effective for treating hepatocellular carcinoma. A histopathologic study

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1001/JAMA.299.14.1669

Chemoembolization for hepatocellular carcinoma

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1001/JAMA.299.14.1669

Thermal ablation for hepatocellular carcinoma

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1001/JAMA.299.14.1669

Treatment of hepatocellular carcinoma by percutaneous tumor ablation methods: Ethanol injection therapy and radiofrequency ablation

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1001/JAMA.299.14.1669

Hepatocellular carcinoma after transcatheter hepatic arterial embolization. A histopathologic study of 84 resected cases

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1001/JAMA.299.14.1669

Multimodal treatment of hepatocellular carcinoma (HCC).

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1001/JAMA.299.14.1669

Hepatocellular carcinoma: radio-frequency ablation of medium and large lesions.

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1001/JAMA.299.14.1669

Treatment of hepatocellular carcinoma by transcatheter arterial embolization combined with intraarterial infusion of a mixture of cisplatin and ethiodized oil

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1001/JAMA.299.14.1669

Rising incidence of hepatocellular carcinoma in the United States

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1001/JAMA.299.14.1669

Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1001/JAMA.299.14.1669

Transarterial embolization versus symptomatic treatment in patients with advanced hepatocellular carcinoma: results of a randomized, controlled trial in a single institution.

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1001/JAMA.299.14.1669

Identifiers

10.1001/JAMA.299.14.1669

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38391223&oldid=2145465826"